Event Brief
Single-Dose Treatment for Sleeping Sickness Approved
Filed: Feb 28, 2026 at 11:03 AM ET
Summary: A new treatment shows up to 96% success in combating sleeping sickness.
WHO: Drugs for Neglected Diseases initiative (DNDi)
WHAT: Approval of a single-dose treatment for sleeping sickness
WHEN: Feb 27, 2026 at 12:19 PM ET
WHERE: Kinshasa
WHY: To provide an effective treatment for T.b. gambiense sleeping sickness
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →